This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 21-27 January 2024 and includes updates on SARS-CoV-2, influenza, cholera, chikungunya, dengue and zika.
The European Centre for Disease Prevention and Control was asked by the European Commission to assess the risk involved in changing the testing requirements for HIV (human immunodeficiency virus), hepatitis B virus (HBV), and hepatitis C virus (HCV) with regard to the quality and safety of non-partner semen donations.
In order to explore whether the current capacity for EU/EEA-wide molecular characterisation for surveillance of HBV and HCV is sufficient to be feasible and what gaps need to be addressed, a survey of EU/EEA Member States was conducted to assess their laboratory capacity and needs in relation to the molecular characterisation of hepatitis B and C.
This report of the European Food Safety Authority and the European Centre for Disease Prevention
and Control presents the results of the zoonoses monitoring activities carried out in 2016 in 37
European countries (28 Member States and nine non-MS).
ECDC Director Marc Sprenger addressed MEPs of the European Parliament’s Committee on the Environment, Public Health and Food Safety regarding the ongoing Ebola virus disease outbreak in West Africa.
On the third meeting of the Hepatitis B and C Network national focal points and experts discussed the enhanced surveillance programme for hepatitis B and C across Europe and explored ways of improving it.
The report presents the results of the zoonoses monitoring activities carried out in 2013 in 32 European countries:eg 28 Member States (MS) and four non-Member States (non-MS) European Free Trade Association (EFTA) countries.